SBIO vs. ARKG
Compare and contrast key facts about ALPS Medical Breakthroughs ETF (SBIO) and ARK Genomic Revolution Multi-Sector ETF (ARKG).
SBIO and ARKG are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. SBIO is a passively managed fund by SS&C that tracks the performance of the S-Network Medical Breakthroughs Index. It was launched on Dec 31, 2014. ARKG is an actively managed fund by ARK Investment Management. It was launched on Oct 31, 2014.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SBIO or ARKG.
Correlation
The correlation between SBIO and ARKG is 0.55, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
SBIO vs. ARKG - Performance Comparison
Loading data...
Key characteristics
SBIO:
-0.38
ARKG:
-0.25
SBIO:
-0.43
ARKG:
-0.01
SBIO:
0.95
ARKG:
1.00
SBIO:
-0.24
ARKG:
-0.12
SBIO:
-0.86
ARKG:
-0.72
SBIO:
17.13%
ARKG:
14.49%
SBIO:
32.63%
ARKG:
46.65%
SBIO:
-63.06%
ARKG:
-83.59%
SBIO:
-53.79%
ARKG:
-80.25%
Returns By Period
In the year-to-date period, SBIO achieves a -14.22% return, which is significantly lower than ARKG's -6.26% return. Over the past 10 years, SBIO has underperformed ARKG with an annualized return of -0.33%, while ARKG has yielded a comparatively higher 0.40% annualized return.
SBIO
-14.22%
12.16%
-30.87%
-12.32%
-5.96%
-0.33%
ARKG
-6.26%
4.95%
-18.59%
-11.37%
-12.34%
0.40%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
SBIO vs. ARKG - Expense Ratio Comparison
SBIO has a 0.50% expense ratio, which is lower than ARKG's 0.75% expense ratio.
Risk-Adjusted Performance
SBIO vs. ARKG — Risk-Adjusted Performance Rank
SBIO
ARKG
SBIO vs. ARKG - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for ALPS Medical Breakthroughs ETF (SBIO) and ARK Genomic Revolution Multi-Sector ETF (ARKG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
SBIO vs. ARKG - Dividend Comparison
SBIO's dividend yield for the trailing twelve months is around 4.14%, while ARKG has not paid dividends to shareholders.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|
SBIO ALPS Medical Breakthroughs ETF | 4.14% | 3.55% | 0.22% | 0.00% | 0.00% | 0.00% | 0.04% | 2.79% | 1.77% |
ARKG ARK Genomic Revolution Multi-Sector ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.62% | 0.85% | 3.14% | 1.94% | 1.34% |
Drawdowns
SBIO vs. ARKG - Drawdown Comparison
The maximum SBIO drawdown since its inception was -63.06%, smaller than the maximum ARKG drawdown of -83.59%. Use the drawdown chart below to compare losses from any high point for SBIO and ARKG. For additional features, visit the drawdowns tool.
Loading data...
Volatility
SBIO vs. ARKG - Volatility Comparison
The current volatility for ALPS Medical Breakthroughs ETF (SBIO) is 12.44%, while ARK Genomic Revolution Multi-Sector ETF (ARKG) has a volatility of 15.88%. This indicates that SBIO experiences smaller price fluctuations and is considered to be less risky than ARKG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...